Blockers of Angiotensin Other Than Olmesartan in Patients With Villous Atrophy: A Nationwide Case-Control Study.

Abstract

OBJECTIVE To examine the association between the previous use of nonolmesartan angiotensin receptor blockers (ARBs) or any angiotensin-converting enzyme inhibitor (ACEI) and subsequent villous atrophy (VA) in patients with small-intestinal VA as compared with general population-matched controls. PATIENTS AND METHODS A case-control study was used to link… (More)
DOI: 10.1016/j.mayocp.2015.04.002

Topics

3 Figures and Tables

Cite this paper

@article{Mrild2015BlockersOA, title={Blockers of Angiotensin Other Than Olmesartan in Patients With Villous Atrophy: A Nationwide Case-Control Study.}, author={Karl M{\aa}rild and Benjamin Lebwohl and Peter H. R. Green and J A Murray and Jonas F Ludvigsson}, journal={Mayo Clinic proceedings}, year={2015}, volume={90 6}, pages={730-7} }